Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 154,810 | 80,920 | 19,080 | 92,810 | 137,200 | 484,820 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 22,247 | 2,970 | 2,000 | 11,637 | 38,854 | |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 177,057 | 83,890 | 21,080 | 92,810 | 148,837 | 523,674 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | |||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | |||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 523,674 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 177,057 | 83,890 | 21,080 | 92,810 | 148,837 | 523,674 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 0 | |||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 0 | |||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 0 | |||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 0 | |||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 177,057 | 83,890 | 21,080 | 92,810 | 148,837 | 523,674 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 22015553 |
| Software Version: | 2022v5.0 |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| Other Expenses.1003 | Information Technology $3600 |
| Other Expenses.1005 | Travel $187 |
| Other Expenses.1 | Annual Conference $102707 |
| Other Expenses.2 | Special Social Events $18486 |
| Other Expenses.3 | Due and Subscription $8112 |
| Other Expenses.4 | Office Expenses and Supplies $6095 |
| Other Expenses.5 | Bank Service Fee $1318 |
| Other Assets.1005 | Accounts Receivable - Beginning $1298 Accounts Receivable - Ending $0 |
| Other Assets.1006 | Pledges and Grants Receivable - Beginning $38800 Pledges and Grants Receivable - Ending $45460 |
| Total Liabilities.1001 | Accounts Payable and Accrued Expenses - Beginning $1500 Accounts Payable and Accrued Expenses - Ending $2500 |
| Form 990-EZ, Part III - Organization's Primary Exempt Purpose | The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is headquartered in San Francisco Bay Area, California. This is the home of the Silicon Valley, the birthplace of biotechnology and one of the largest biomedical cluster with the highest venture capital investment in the world. There are more than a thousand biopharmaceutical/biotech companies in this area, including several large biopharmaceuticals such as Amgen, Genentech and Gilead. CABS is a highly influential association with more than 3000 members and subscribers in the life sciences industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life sciences corporations. Many of our members are experts and leaders, innovative entrepreneurs, lawyers and venture capitalists or investors in the life sciences sector. CABS is the largest and most active Chinese biopharmaceutical association in Northern America. We organize many activities to promote the international collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in the Pacific Rim with an excellent platform to promote business and to recruit talent. In addition to year-round technology and business seminars, the annual BioPacific Conference organized by CABS is a highly anticipated event that attracts hundreds of biopharmaceutical professionals and business leaders.CABS is helping members seeking collaboration opportunties in the Pacific Rim. To further meet the needs of CABS members, we are actively helping our members seeking partnership opportunities in the Pacific Rim in the following areas.To co-sponsor scientific conferences in biopharmaceutical field;To organize CABS delegations to visit science parks and life sciences companies in the Pacific Rim for potential collaborations;To organize CABS delegations to visit science parks and life sciences companies for potential collaborations;To invite leaders in biopharmaceutical industry from Pacific Rim for seminars/talks, especially for the annual CABS BioPacific Conference;To fulfill our mission, we organize frequent activities, such as scientific and business workshops and social/networking events. Our flagship event is our annual conference, the BioPacific Conference, which attracts about 600 attendees from the U.S. and the Pacific Rim. |
| Form 990-EZ, Part III - Line 28 Program Service Accomplishments | Program Services:BioPacific Conference 2022, (CABS 23rd Annual Conference)November 12, 2022; San Mateo Marriott San Francisco AirportRegistration Revenue: $8,855; Program Expenses: $102,707Annual BioPacific Conference, a scientific and professional conference, is the major program for the Organization to accomplish its missions to provide general education to the biotechnology and pharmaceutical industries, to promote interactions among biotechnology and academic professionals and to promote international collaborations.Its 23rd annual conference was hosted on November 22, 2022 at San Mateo Marriott San Francisco Airport located at 1770 S Amphlett Blvd., San Mateo, CA 94402. The conferrence named as Resilience and Ingenuity - Embracing Opportunities in a New Normal. The 23rd annnual conference showcased success stories and best practives for innovation and improving the resilience of organizations. As our first in-person conference since the COVID-19 pandemic, it had 42 distinguished speakers/panelists/moderators, 51 sponsors, and attracted more than 600 attendees. The amazing success would have not been possible without the contributions and participation of all the speakers, sponsors, attendees, organizing committee members and volunteers.The theme of the Conference was Resilience and Ingenuity, Embracing Opportunities in a New Normal. The conference included 3 keynote talks, 1 K. Fong Award speech,1 fireside chat, 4 scientific speeches, 5 panel discussions, and 9 breakout room presentations, all by industry and academic leaders. These exciting talks and panels were grouped into 2 morning sessions, 2 noon sessions, 2 afternoon sessions, and the inaugural China Night session. Best practices for small molecule drug discovery A new class of oncology drug targets Winner of the 2022 CABS K. Fong Award in Life Sciences Success stories from pharma entrepreneurs Building a robust drug candidate pipeline Pharma partnering and investment strategies New technologies for studying protein structures Targeting an oncoprotein previously thought to be undruggable Leveraging digital technologies to accelerate medical innovation China-US cross-border collaboration with large pharmaceutical companies |
| Form 990-EZ, Part III - Line 29 Program Service Accomplishments | Workshop and Symposium:Program Revenue: $-0- Program Expenses: $-0-The organization's another major program service is to organize and host the workshops and symposiums for the life science with scientists, professionals and public as well. For the fiscal year ended 08/31/2023, as the examples, the major workshops and symposiums the organization organized are the following:-Immunogenicity of Biologic Drugs - Clinical Relevance case studies, Predictive Tools & Challenges with New Modalities (09/15/2022)-Strategically Mapping Your Career (03/25/2023)-Recap pf CABS 2023 Career Advisory Network Program Kickoff Meeting (04/22/2023)-Advancing Healthcare Through Innovation (05/14/2023)-Accelerating the Development and Manufacturing of Drugs in Various Modalities (06/03/2023)More than several hundreds people including scientists in the life science, professionals in various trainings, businesses in bio/pharmaceutical industries as well as public attended these workshops and symposiums. |
| Form 990-EZ, Part III - Line 30 Program Service Accomplishments | Special Social Events:Program Revenue: $-0- Program Expenses: $2,782The organization is also organized special social events as the bridge to connect with professionals and industries crossed the country and world as well as the communities as the general public.In the fiscal year ended 08/31/2023, the organization hosted many events to introduce biopharmaceutical companies, science parks and venture capital firms from the Pacific Rim to our members. These events were focused on career opportunities and entrepreneurship for its members as well as general public.The organization was also organized its BioPacific Toastmasters Club open houses for the CABS members with their families and friends. This social event promoted the networking between the professionals in the life science as well as increased the interactions with the public for the awareness of the development of life science. Couple of hundred people were benefited from this particular event.The major social events organized in this fiscal year by the organization were the follows:-Welcome to CABS 2023 Chinese New Year Celebration Party (02/04/2023)-CABS 2023 Summer BBQ (08/27/2023) |
| Software ID: | 22015553 |
| Software Version: | 2022v5.0 |